GMO Pie is a modern hybrid strain, though its exact origins and development history remain undocumented. Breeders have not publicly confirmed the specific cross behind this variety, and its lineage beyond the reported Georgia Pie influence is considered incomplete. Due to this lack of official breeder data, the specific provenance of the plant is held to be a mystery within the horticultural community, with no verified information regarding the timeframe or location of its original selection.

The chemical profile of GMO Pie is defined by a primary dominance of caryophyllene, followed by limonene, linalool, humulene, bisabolol, beta-pinene, pinene, myrcene, and terpinolene. Because these values are derived from verified lab data, the strain consistently exhibits this specific aromatic structure. Regarding potency, the strain is THC-dominant, with an estimated THC content of approximately 24.1 percent and an estimated CBD concentration of 0.06 percent. Users can expect the sensory experience to reflect this diverse terpene hierarchy, rooted in the spicy, woody, and floral notes inherent to its confirmed chemical makeup.

Consumers report that the effects of GMO Pie are characterized by feelings of relaxation, happiness, and an uplifted state of mind. Given these reported qualities, the strain is frequently selected as a resource for managing stress, pain, and sleep difficulties. Growing this hybrid is considered a moderate challenge, suitable for both indoor and outdoor cultivation environments. Under proper conditions, the plant reaches maturity after a 65-day flowering period and is known to produce a high yield. There are currently no notable offspring recorded for this strain in public registers.